GGrantIndex
← Leaderboards

George A Ricaurte

Johns Hopkins University

$14,201,416
Attributed
$14,201,416
Total exposure
24
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $2.1M · FY200513
$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13

Funding mix

By agency

NIH$14,201,416 · 24

By mechanism

R01$12,181,785 · 8
M01$874,044 · 14
K05$644,521 · 1
K02$501,066 · 1

Top collaborators

No co-investigators on record.

Most similar at Johns Hopkins University

Same institution · by research overlap

Others in their field

Top investigators on “Serotonin

Research focus

SerotoninHuman SubjectClinical ResearchNeurotoxicologyDopamineDrug AbuseNeurotoxins3,4 MethylenedioxymethamphetaminePositron Emission TomographyMethamphetamineSaimiriNeuronsDrug Adverse EffectNeuropharmacologyAmphetaminesCognitionFenfluramineNeurotoxicBioimaging /Biomedical ImagingExperimental Brain LesionAnimalsNeurotoxicityDopamine TransporterNeuropsychiatry

Grant awards (59)

PET Studies of Amphetamine Treatment of ADHD$504,366
R01 · FY2013 · MH · contact PI
PET Studies of Amphetamine Treatment of ADHD$525,383
R01 · FY2012 · MH · contact PI
PET Studies of Amphetamine Treatment of ADHD$525,384
R01 · FY2011 · MH · contact PI
PET Studies of Amphetamine Treatment of ADHD$530,688
R01 · FY2010 · MH · contact PI
PET Studies of Amphetamine Treatment of ADHD$454,686
R01 · FY2009 · MH · contact PI
Studies of Substituted Amphetamine Neurotoxicity$128,902
K05 · FY2009 · DA · contact PI
Studies of Substituted Amphetamine Neurotoxicity$128,902
K05 · FY2008 · DA · contact PI
ADHD Treatment & Amphetamine Neurotoxicity$377,209
R01 · FY2007 · HD · contact PI
Studies of Substituted Amphetamine Neurotoxicity$128,902
K05 · FY2007 · DA · contact PI
MDMA NEUROTOXICITY IN HUMANS: OCCURRENCE AND CONSEQUENCES$24,734
M01 · FY2007 · RR · contact PI
Methamphetamine Neurotoxicity in Nonhuman Primates$446,527
R01 · FY2006 · DA · contact PI
MDMA Neurotoxicity in Humans: Occurence & Consequences$396,114
R01 · FY2006 · DA · contact PI
ADHD Treatment & Amphetamine Neurotoxicity$376,010
R01 · FY2006 · HD · contact PI
MDMA NEUROTOXICITY IN HUMANS: OCCURRENCE AND CONSEQUENCES$196,378
M01 · FY2006 · RR · contact PI
Studies of Substituted Amphetamine Neurotoxicity$128,913
K05 · FY2006 · DA · contact PI
PET STUDIES OF METHAMPHTAMINE NEUROTOXICITY IN HUMANS$9,379
M01 · FY2006 · RR · contact PI
PET STUDIES OF HUMANS EXPOSED TO MDMA (ECSTASY)$1,759
M01 · FY2006 · RR · contact PI
MDMA Neurotoxicity in Nonhuman Primates$490,541
R01 · FY2005 · DA
Methamphetamine Neurotoxicity in Nonhuman Primates$447,567
R01 · FY2005 · DA
MDMA Neurotoxicity in Humans: Occurence &Consequences$405,738
R01 · FY2005 · DA
ADHD Treatment &Amphetamine Neurotoxicity$372,796
R01 · FY2005 · HD
MDMA NEUROTOXICITY IN HUMANS: OCCURRENCE AND CONSEQUENCES$195,617
M01 · FY2005 · RR
Studies of Substituted Amphetamine Neurotoxicity$128,902
K05 · FY2005 · DA
PET STUDIES OF METHAMPHTAMINE NEUROTOXICITY IN HUMANS$42,318
M01 · FY2005 · RR
PET STUDIES OF HUMANS EXPOSED TO MDMA (ECSTASY)$12,774
M01 · FY2005 · RR
Methamphetamine Neurotoxicity in Nonhuman Primates$448,900
R01 · FY2004 · DA
MDMA Neurotoxicity in Humans: Occurence &Consequences$405,825
R01 · FY2004 · DA
MDMA Neurotoxicity in Humans: Occurrence and Consequences$317,140
M01 · FY2004 · RR
MDMA Neurotoxicity in Nonhuman Primates$193,032
R01 · FY2004 · DA
PET Studies of Methamphtamine Neurotoxicity in Humans$46,011
M01 · FY2004 · RR
Pet Studies of Humans Exposed to MDMA (Ecstasy)$27,934
M01 · FY2004 · RR
MDMA Neurotoxicity in Nonhuman Primates$462,383
R01 · FY2003 · DA
Methamphetamine Neurotoxicity in Nonhuman Primates$445,344
R01 · FY2003 · DA
MDMA Neurotoxicity in Humans: Occurence &Consequences$405,910
R01 · FY2003 · DA
SUBSTITUTED AMPHETAMINE NEUROTOXICITY$125,388
K02 · FY2003 · DA
MDMA Neurotoxicity in Nonhuman Primates$456,242
R01 · FY2002 · DA
Methamphetamine Neurotoxicity in Nonhuman Primates$436,440
R01 · FY2002 · DA
MDMA Neurotoxicity in Humans: Occurence &Consequences$392,086
R01 · FY2002 · DA
GENE EXPRESSION AND METHAMPHETAMINE NEUROTOXICITY$367,875
R01 · FY2002 · DA
SUBSTITUTED AMPHETAMINE NEUROTOXICITY$125,388
K02 · FY2002 · DA
SAFETY ASSESSMENT OF FENFLURAMINE &PHENTERMINE IN HUMANS$0
M01 · FY2002 · RR
PET &CSF STUDIES OF HUMANS EXPOSED TO MDMA (ECSTASY)$0
M01 · FY2002 · RR
MDMA NEUROTOXICITY IN HUMANS-- OCCURENCE &CONSEQUENCE$0
M01 · FY2002 · RR
SAFETY ASSESSMENT OF FENFLURAMINE/PHENTERMINE$511,489
R01 · FY2001 · DA
GENE EXPRESSION AND METHAMPHETAMINE NEUROTOXICITY$367,875
R01 · FY2001 · DA
SUBSTITUTED AMPHETAMINE NEUROTOXICITY$125,388
K02 · FY2001 · DA
SAFETY ASSESSMENT OF FENFLURAMINE &PHENTERMINE IN HUMANS$0
M01 · FY2001 · RR
PET &CSF STUDIES OF HUMANS EXPOSED TO MDMA (ECSTASY)$0
M01 · FY2001 · RR
MDMA NEUROTOXICITY IN HUMANS-- OCCURENCE &CONSEQUENCE$0
M01 · FY2001 · RR
PET STUDIES OF METHAMPHETAMINE NEUROTOXICITY IN HUMANS$545,480
R01 · FY2000 · DA
SAFETY ASSESSMENT OF FENFLURAMINE/PHENTERMINE$503,992
R01 · FY2000 · DA
GENE EXPRESSION AND METHAMPHETAMINE NEUROTOXICITY$385,903
R01 · FY2000 · DA
SUBSTITUTED AMPHETAMINE NEUROTOXICITY$124,902
K02 · FY2000 · DA
PET STUDIES OF METHAMPHETAMINE NEUROTOXICITY ON HUMANS$0
M01 · FY2000 · RR
ASSESSMENT OF FENFLURAMINE &PHENTERMINE IN HUMANS$0
M01 · FY2000 · RR
ASSESSMENT OF FENFLURAMINE &PHENTERMINE IN HUMANS$0
M01 · FY2000 · RR
ASSESSMENT OF FENFLURAMINE &PHENTERMINE IN HUMANS$0
M01 · FY2000 · RR
PET &CSF STUDIES OF HUMANS EXPOSED TO MDMA$0
M01 · FY2000 · RR
MDMA NEUROTOXICITY IN HUMANS-- OCCURENCE &CONSEQUENCE$0
M01 · FY2000 · RR